Form 8-K - Current report:
SEC Accession No. 0001641172-25-009309
Filing Date
2025-05-08
Accepted
2025-05-08 17:12:01
Documents
24
Period of Report
2025-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 69635
2 EX-1.1 ex1-1.htm EX-1.1 145477
3 EX-4.1 ex4-1.htm EX-4.1 93730
4 EX-4.2 ex4-2.htm EX-4.2 156784
5 EX-4.3 ex4-3.htm EX-4.3 121554
6 EX-10.1 ex10-1.htm EX-10.1 260332
7 EX-99.1 ex99-1.htm EX-99.1 15089
8 EX-99.2 ex99-2.htm EX-99.2 16620
9 GRAPHIC ex99-1_001.jpg GRAPHIC 69085
10 GRAPHIC ex99-2_001.jpg GRAPHIC 53430
  Complete submission text file 0001641172-25-009309.txt   1457597

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE biaf-20250505.xsd EX-101.SCH 3785
12 XBRL DEFINITION FILE biaf-20250505_def.xml EX-101.DEF 26626
13 XBRL LABEL FILE biaf-20250505_lab.xml EX-101.LAB 36673
14 XBRL PRESENTATION FILE biaf-20250505_pre.xml EX-101.PRE 25250
27 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5815
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 25927352
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)